Barbara Fox
Vorstandsvorsitzender bei Rheos Medicines, Inc.
Profil
Barbara S.
Fox was the founder of Avaxia Biologics, Inc. (founded in 2005) and Recovery Pharmaceuticals, Inc. (founded in 1998), where she held the titles of Chief Executive Officer & Director and President & Chief Scientific Officer, respectively.
Currently, she is the Chief Executive Officer at Rheos Medicines, Inc. (since 2019) and an Advisor at The Engine Accelerator, Inc. (current job).
Her former positions include Chief Executive Officer & Director at Tilos Therapeutics, Inc., Vice President-Immunology at ImmuLogic Pharmaceutical Corp., and Associate Professor at University of Maryland Medical System Corp.
Dr. Fox holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Bryn Mawr College.
Aktive Positionen von Barbara Fox
| Unternehmen | Position | Beginn |
|---|---|---|
Rheos Medicines, Inc.
 Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 21.10.2019 |
The Engine Accelerator, Inc.
 The Engine Accelerator, Inc. Investment ManagersFinance The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts. | Berater | - |
Ehemalige bekannte Positionen von Barbara Fox
| Unternehmen | Position | Ende |
|---|---|---|
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. BiotechnologyHealth Technology Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA. | Vorstandsvorsitzender | 21.10.2019 |
University of Maryland Medical System Corp.
 University of Maryland Medical System Corp. Hospital/Nursing ManagementHealth Services University of Maryland Medical System Corp. provides health care system. Its services include University of Maryland health advantage plan, University of Maryland quality care network, University of Maryland cancer network and diabetes network. The firm offers referral center for trauma, cancer care, neurocare, cardiac care, women's and children's health and physical rehabilitation. The company was founded in 1984 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | - |
| Recovery Pharmaceuticals, Inc. | Gründer | - |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Corporate Officer/Principal | - |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Gründer | - |
Ausbildung von Barbara Fox
| Massachusetts Institute of Technology | Doctorate Degree |
| Bryn Mawr College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Health Technology |
University of Maryland Medical System Corp.
University of Maryland Medical System Corp. Hospital/Nursing ManagementHealth Services University of Maryland Medical System Corp. provides health care system. Its services include University of Maryland health advantage plan, University of Maryland quality care network, University of Maryland cancer network and diabetes network. The firm offers referral center for trauma, cancer care, neurocare, cardiac care, women's and children's health and physical rehabilitation. The company was founded in 1984 and is headquartered in Baltimore, MD. | Health Services |
| Recovery Pharmaceuticals, Inc. | |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. BiotechnologyHealth Technology Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA. | Health Technology |
The Engine Accelerator, Inc.
The Engine Accelerator, Inc. Investment ManagersFinance The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Health Technology |
